Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosis
Ann Neurol
.
1995 Jan;37(1):5-6.
doi: 10.1002/ana.410370104.
Authors
J N Whitaker
,
G W Mitchell
,
G R Cutter
PMID:
7818258
DOI:
10.1002/ana.410370104
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Immunosuppression Therapy*
Methotrexate / therapeutic use*
Multiple Sclerosis / drug therapy*
Treatment Outcome
Substances
Methotrexate